Project Details
Description
EPG-HU1418-201; A Phase 2/3, Single-Arm Study with 2 Cohorts to Characterize and Evaluate the Efficacy, Safety, and Tolerability of hu14.18K322A ...
| Status | Active |
|---|---|
| Effective start/end date | 10/10/25 → 10/9/36 |
Funding
- RENAISSANCE PHARMA LTD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.